| All patients (n = 428) | Ongoing CR (n = 77) | Died < 6 months (n = 69) | No local therapy** (n = 230) | NED or NPRD (n = 52) |
---|---|---|---|---|---|
Median age (IQR) | 65 (55 – 74) | 68 (55 – 75) | 65 (58 – 74) | 64 (55 – 74) | 61 (54 – 70) |
Gender | 63% male | 68% male | 67% male | 61% male | 62% male |
Stage before CPI  Stage M1a (%)  Stage M1b (%)  Stage M1c (%)  Stage M1d (%) | 99 (23%) 90 (21%) 152 (36%) 87 (20%) | 22 (29%) 21 (27%) 31 (40%) 3 (4%) | 11 (16%) 8 (12%) 36 (52%) 14 (20%) | 55 (24%) 53 (23%) 69 (30%) 53 (23%) | 11 (21%) 8 (15%) 16 (31%) 17 (33%) |
Sun-shielded* | 93 (22%) | 5 (6%) | 19 (28%) | 54 (23%) | 15 (29%) |
1st Therapy (%)  CTLA4  PD1 or PDL1  CTLA4 + PD1 | 124 (29%) 129 (30%) 175 (41%) | 11 (14%) 23 (30%) 43 (56%) | 28 (41%) 23 (33%) 18 (26%) | 69 (30%) 71 (31%) 90 (39%) | 16 (31%) 12 (23%) 24 (46%) |